Overview

Diazepam is a benzodiazepine medication widely used as a central nervous system depressant with anxiolytic, anticonvulsant, sedative and muscle‑relaxant properties. As with other drugs in its class, diazepam enhances the effect of the inhibitory neurotransmitter GABA at the GABA‑A receptor; further information on the class is available here. Diazepam is noted for a relatively long half‑life compared with many benzodiazepines and for producing clinically meaningful effects that may persist because of active metabolites.

Mechanism of action

Diazepam is a positive allosteric modulator of the GABA‑A receptor: it increases the frequency of chloride channel opening in response to GABA, which reduces neuronal excitability. This mechanism underlies its sedative, anxiolytic, anticonvulsant and muscle‑relaxant actions. The onset and depth of effect vary with dose, route of administration and patient factors.

Pharmacokinetics

The drug is lipophilic, readily absorbed after oral administration, and redistributes to the brain. Hepatic metabolism produces active metabolites that can prolong clinical effects, contributing to its long apparent duration in some patients. Renal and hepatic function, age and concomitant medicines influence elimination and effect.

Medical uses

Diazepam is prescribed for several short‑term clinical indications. Common uses include:

Formulations and administration

Diazepam is available in multiple formulations: oral tablets and solutions, injectable preparations for intravenous or intramuscular use, and rectal gel for out‑of‑hospital seizure rescue. Choice of formulation depends on the clinical scenario, required speed of effect and setting.

Adverse effects and interactions

Common adverse effects include drowsiness, dizziness, impaired coordination and cognitive slowing. When combined with other central nervous system depressants—most importantly alcohol and opioid analgesics—diazepam increases the risk of profound sedation and respiratory depression. Clinicians counsel patients about these interactions and avoid concomitant use where possible.

With repeated or prolonged use, benzodiazepines can produce tolerance (reduced effect over time) and physical dependence, leading to withdrawal symptoms if the drug is stopped abruptly. For this reason many guidelines recommend limiting treatment to brief courses for acute problems and using alternative long‑term strategies when appropriate; diazepam is generally used for acute indications and short durations to reduce dependence risk. Concerns about misuse and addiction are well documented in clinical guidance resources.

Overdose and emergency care

Isolated benzodiazepine overdose is often reversible with supportive care; severe poisoning is more likely when benzodiazepines are combined with other depressants. Flumazenil is an antagonist that can reverse benzodiazepine effects in selected situations but is used cautiously because of seizure risk in some patients.

Special populations and precautions

Use in older adults requires dose adjustment and careful monitoring because of increased sensitivity, fall risk and slower elimination. Use during pregnancy and lactation is typically avoided when possible; exposure near delivery can cause neonatal sedation and withdrawal. Decisions are individualized, weighing maternal benefits and potential fetal or neonatal risks.

History and status

First marketed under the trade name Valium, diazepam became one of the most widely prescribed psychotropic medications in the decades after its introduction and has been used both medically and recreationally for its calming effects. The World Health Organization lists diazepam among essential medicines for certain indications, reflecting its recognized role in acute care classification. Patterns of prescribing vary by country and over time; public health efforts encourage careful prescribing, monitoring and patient education to limit misuse and harms, as seen in national reports such as those from the United States.

For practical clinical details, dosing, contraindications and local regulatory advice consult authoritative prescribing resources and clinical guidelines rather than relying solely on summary information.